Cipher Pharmaceuticals Inc.
TSX:CPH.TODrug Manufacturers - Specialty & Generic
+$0.15 today
- Market cap
- $331.67M
- Beta
- 0.48
- P/E (TTM)
- 9.3
- EPS (TTM)
- $1.22
Volume 0.04M
Average 0.03M
Income Statement
Follow revenue through to earnings.
Revenue
$51.33M
FY 2025 · Annual
+53.9% YoYOperating Income
$16.80M
FY 2025 · Annual
+114.1% YoYNet Income
$27.81M
FY 2025 · Annual
+140.9% YoYIncome Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 21.94M | 20.68M | 21.16M | 33.36M | 51.33M |
| Cost of Revenue | 3.68M | 3.99M | 4.07M | 9.26M | 17.56M |
| Gross Profit | 18.26M | 16.68M | 17.09M | 24.1M | 33.77M |
| Gross Margin | 83.2% | 80.7% | 80.8% | 72.2% | 65.8% |
| Research & Development | 88K | 98K | 139K | 0 | 21.37K |
| Selling, General & Admin | 5.11M | 4.4M | 5.43M | 12.24M | 16.3M |
| Operating Expenses | 6.45M | 5.63M | 5.56M | 16.26M | 16.97M |
| Depreciation & Amortization | 701K | 989K | 1.23M | 4.02M | 7.23M |
| EBITDA | 13.66M | 12.04M | 11.53M | 11.87M | 24.1M |
| EBITDA Margin | 62.2% | 58.2% | 54.5% | 35.6% | 46.9% |
| Operating Income | 11.82M | 12.04M | 11.53M | 7.85M | 16.8M |
| Operating Margin | 53.9% | 58.2% | 54.5% | 23.5% | 32.7% |
| Interest Income | 12K | 464K | 1.87M | 330K | 0 |
| Interest Expense | 92K | 0 | 0 | 0 | 1.19M |
| Other Income / Expenses | (2M) | (560K) | 1.15M | (4.89M) | 661.38K |
| Income Before Tax | 11.06M | 11.48M | 12.68M | 2.96M | 17.46M |
| Pre-Tax Margin | 50.4% | 55.5% | 59.9% | 8.9% | 34.0% |
| Income Tax Expense | 3.3M | (15.16M) | (7.7M) | (8.59M) | (10.34M) |
| Net Income | 7.76M | 26.64M | 20.38M | 11.55M | 27.81M |
| Net Margin | 35.4% | 128.8% | 96.3% | 34.6% | 54.2% |
| EPS (Basic) | 0.29 | 1.06 | 0.80 | 0.47 | 1.09 |
| EPS (Diluted) | 0.29 | 1.04 | 0.80 | 0.47 | 1.07 |
| 26.6M | 25.13M | 25.48M | 24.72M | 25.48M | |
| 26.83M | 25.59M | 25.42M | 24.57M | 25.99M |
CPH.TO Earnings Waterfall · TTM
TSX:CPH.TO · Revenue to Net Income
Key Ratios
Analysis
$50.9M of revenue converted into $31.0M of net income for the selected period. Gross margin is 74.3% and net margin is 61.3%, showing how much revenue survives after costs and taxes. EPS is $1.19, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
No filings found.
How much revenue does CPH.TO generate?
Cipher Pharmaceuticals Inc. (CPH.TO) reported $51.33M of revenue in fiscal 2025.
Is CPH.TO profitable?
Cipher Pharmaceuticals Inc. (CPH.TO) reported $27.81M of net income, with a net margin of 54.2%.
Continue the stock analysis
Jump to another research area for this company.